Novartis AG (NVSEF) is expected to report earnings on Tuesday, October 27, 2026, after the close. Consensus EPS estimate is $2.23.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-21 | FY2026 Q2 | $2.17 | $1.68 | -22.6% | $14.09B |
| 2026-04-28 | FY2026 Q1 | $2.10 | $1.62 | -22.9% | $12.86B |
| 2026-02-04 | FY2025 Q4 | $1.99 | $1.27 | -36.2% | $13.44B |
| 2025-10-28 | FY2025 Q3 | $2.27 | $2.02 | -11.0% | $14.36B |
| 2025-06-30 | FY2025 Q2 | $2.35 | $2.42 | +3.0% | $14.05B |
| 2025-03-31 | FY2025 Q1 | $2.11 | $2.28 | +8.1% | $13.23B |
| 2025-01-31 | FY2024 Q4 | $1.80 | $1.42 | -21.1% | $13.56B |
| 2024-09-30 | FY2024 Q3 | $1.94 | $2.06 | +6.2% | $12.82B |
NVSEF has beaten consensus EPS in 3 of its last 8 reported quarters.
See NVSEF on the live calendar →